Since the inception of research into terahertz (THz) radiation, scientists have been captivated by its potential to transform various fields,...
Cabozantinib, an innovative oral tyrosine kinase inhibitor, has recently received approval from the U.S. Food and Drug Administration (FDA) for...
Researchers at the National Cancer Research Centre (CNIO) have unveiled a groundbreaking discovery concerning liver regeneration mechanisms in mice, as...
Cleveland has recently emerged as a focal point in the study of cellular stress responses, especially within the framework of...
The COVID-19 pandemic has had profound implications for healthcare systems worldwide, particularly in the domain of cancer prevention and diagnosis....
The Food and Drug Administration (FDA) has taken a significant step in the advancement of therapeutic interventions by approving over...
Researchers at the University of Colorado Cancer Center have unveiled a significant breakthrough in understanding the cellular mechanisms that could...
Yale researchers have uncovered a groundbreaking approach to elicit immune responses against previously neglected tumors, utilizing a notable antibody that...
Prostate cancer remains a significant public health issue, accounting for the second-highest number of cancer-related deaths in American men. The...
Breast cancer remains a significant global health challenge, impacting millions of women across different cultures and demographics. Recent findings from...
In a groundbreaking study published in Scientific Reports, a team of researchers from YOKOHAMA National University has unveiled a novel...
New research published in the renowned journal "CA: A Cancer Journal for Clinicians" offers compelling insights into the significant advancements...
In a groundbreaking development in the field of oncology, City of Hope, one of the foremost cancer research and treatment...
Human papillomavirus (HPV) has long been recognized for its role in various cancers, particularly cervical cancer. However, new research presented...
Patients diagnosed with specific subtypes of breast cancer may face significant risks if surgical treatment is delayed beyond 42 days...
On the forefront of cancer research, a groundbreaking study has emerged, shedding light on how to enhance the efficacy of...
Type I interferons are pivotal proteins produced by the cells of the immune system in response to viral infections. They...
Recent advances in immunotherapy have revolutionized the treatment landscape for B-cell acute lymphoblastic leukemia (B-ALL), a particularly aggressive form of...
Chemotherapy combined with immunotherapy has emerged as a pivotal first-line strategy for treating patients diagnosed with extensive-stage small cell lung...
John Turchi, PhD, Takes Helm as Executive Director of the Tom and Julie Wood Center for Lung Cancer Research The...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.